ADR Biomedical Holdings Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 846.00
-2.00 (-0.24%)
Sep 17, 2026, 3:30 PM JST
ADR Biomedical Holdings Market Cap
ADR Biomedical Holdings has a market cap or net worth of 7.57 billion as of September 16, 2026. Its market cap has decreased by -10.64% in one year.
Market Cap
7.57B
Enterprise Value
7.75B
Revenue
101.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
846.00
ChartMarket Cap Chart
Since June 28, 2006, ADR Biomedical Holdings's market cap has decreased from 8.22B to 7.57B, a decrease of -7.88%. That is a compound annual growth rate of -0.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 7.57B | 0.95% |
| Dec 30, 2025 | 7.50B | -2.89% |
| Dec 30, 2024 | 7.72B | -24.06% |
| Dec 29, 2023 | 10.17B | -6.18% |
| Dec 30, 2022 | 10.84B | -4.64% |
| Dec 30, 2021 | 11.37B | -10.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellSeed | 8.91B |
| Nano Holdings | 8.76B |
| BrightPath Biotherapeutics | 8.33B |
| Kidswell Bio | 8.09B |
| StemCell Institute | 7.54B |
| J-Pharma | 7.28B |
| SUSMED,Inc. | 7.10B |
| Chiome Bioscience | 6.94B |